Peter Rhode
Technik-/Wissenschafts-/F&E-Leiter bei HCW BIOLOGICS INC.
Vermögen: 84 475 $ am 31.05.2024
Profil
Peter R.
Rhode is the founder of Sunol Molecular Corp., which was founded in 1996.
He held the title of Research Director from 1996 to 2002.
Dr. Rhode is currently working as the Chief Scientific Officer & VP-Clinical Operations at HCW Biologics Inc. since 2019.
In the past, he worked as a Senior Scientist at Baxter International, Inc. from 1991 to 1996, and as the Senior Vice President-Research & Development at Altor BioScience Corp.
from 2002 to 2019.
Dr. Rhode obtained a doctorate degree from the University of Wisconsin and an undergraduate degree from the University of California, Davis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
HCW BIOLOGICS, INC.
0,20% | 15.04.2024 | 77 500 ( 0,20% ) | 84 475 $ | 31.05.2024 |
Aktive Positionen von Peter Rhode
| Unternehmen | Position | Beginn |
|---|---|---|
| HCW BIOLOGICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2019 |
Ehemalige bekannte Positionen von Peter Rhode
| Unternehmen | Position | Ende |
|---|---|---|
Altor BioScience Corp.
 Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Altor BioScience Corp. operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer. Its product candidates include ALT-801, a T-cell receptor-targeted immunotherapeutic for cancer and ALT-836, a monoclonal antibody-based tissue factor antagonist treatment of patients with acute respiratory distress syndrome and acute lung injury. The company was founded by Hing C. Wong in 2002 and is headquartered in Miramar, FL. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 |
Sunol Molecular Corp.
 Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Part of ImmunityBio, Inc., Sunol Molecular Corp. is a company that develops gel therapeutics to treat disorders associated with the human tissue factor. The company is based in Miramar, FL. The company was founded by Hing C. Wong, Jon Weidanz, Peter R. Rhode. Sunol Molecular was acquired by Altor BioScience Corp., part of ImmunityBio, Inc. from August 01, 2017 on March 25, 2005. | Gründer | 01.01.2002 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.01.1996 |
Ausbildung von Peter Rhode
| University of Wisconsin | Doctorate Degree |
| University of California, Davis | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| HCW BIOLOGICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Altor BioScience Corp.
Altor BioScience Corp. Pharmaceuticals: MajorHealth Technology Altor BioScience Corp. operates as a biopharmaceutical company which develops therapeutic products for the treatment of cancer. Its product candidates include ALT-801, a T-cell receptor-targeted immunotherapeutic for cancer and ALT-836, a monoclonal antibody-based tissue factor antagonist treatment of patients with acute respiratory distress syndrome and acute lung injury. The company was founded by Hing C. Wong in 2002 and is headquartered in Miramar, FL. | Health Technology |
Sunol Molecular Corp.
Sunol Molecular Corp. Pharmaceuticals: MajorHealth Technology Part of ImmunityBio, Inc., Sunol Molecular Corp. is a company that develops gel therapeutics to treat disorders associated with the human tissue factor. The company is based in Miramar, FL. The company was founded by Hing C. Wong, Jon Weidanz, Peter R. Rhode. Sunol Molecular was acquired by Altor BioScience Corp., part of ImmunityBio, Inc. from August 01, 2017 on March 25, 2005. | Health Technology |
